Targeted radionuclide therapy for neuroendocrine tumours: principles and application.
Neuroendocrine tumours comprise a group of neoplasms with variable clinical behaviour. Their growth and spread is often very slow and initially asymptomatic, and thus they are often metastatic at the time of diagnosis and incurable by surgery. An exciting therapeutic strategy for cytoreduction, both...
Main Authors: | Druce, MR, Lewington, V, Grossman, AB |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2010
|
Similar Items
-
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours.
by: Kaltsas, G, et al.
Published: (2004) -
Radionuclide treatment of neuroendocrine tumours with the novel radiolabelled analogue Y-90-SMT 487
by: Carroll, P, et al.
Published: (2003) -
Update on neuroendocrine tumours
by: Grossman, AB
Published: (2012) -
Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
by: Gupta, P, et al.
Published: (2014) -
Are serotonin metabolite levels related to bone mineral density in patients with neuroendocrine tumours?
by: Sen Gupta, P, et al.
Published: (2014)